{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:46:53Z","timestamp":1789008413919,"version":"build-2803163510"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"DOI":"10.1186\/s13065-026-01772-7","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T04:15:23Z","timestamp":1774325723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Surface-modified nanocarriers in the design of targeted drug delivery systems for parasitic diseases: a comprehensive review"],"prefix":"10.1186","volume":"20","author":[{"given":"Chinekwu S.","family":"Nwagwu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agatha A.","family":"Ugwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinazom P.","family":"Agbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adaeze L.","family":"Onugwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabastine O.","family":"Onugwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel W.","family":"Uzondu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozioma B.","family":"Onokala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Emencheta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A.","family":"Attama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra O.","family":"Nnamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"1772_CR1","doi-asserted-by":"crossref","unstructured":"Sinha S, Sehgal R. Chapter 11 - Nano-targeted drug delivery for parasitic infections. In: Saravanan M, Barabadi H, Mostafavi E, Webster T, editors. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance. Elsevier; 2022. pp. 395\u2013424. (Micro and Nano Technologies). Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780323907927000105. Accessed 6 Oct 2024.","DOI":"10.1016\/B978-0-323-90792-7.00010-5"},{"key":"1772_CR2","doi-asserted-by":"publisher","first-page":"102426","DOI":"10.1016\/j.jddst.2021.102426","volume":"62","author":"A Shah","year":"2021","unstructured":"Shah A, Aftab S, Nisar J, Ashiq MN, Iftikhar FJ. Nanocarriers for targeted drug delivery. J Drug Deliv Sci Technol. 2021;62:102426.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1772_CR3","doi-asserted-by":"publisher","first-page":"6407","DOI":"10.2147\/IJN.S206109","volume":"14","author":"CQ Quezada","year":"2019","unstructured":"Quezada CQ, Azevedo CS, Charneau S, Santana JM, Chorilli M, Carneiro MB, et al. Advances in nanocarriers as drug delivery systems in Chagas disease>. Int J Nanomed. 2019;14:6407\u201324.","journal-title":"Int J Nanomed"},{"key":"1772_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/978-3-031-39020-3_11","volume-title":"Nanomedicines for the Prevention and Treatment of Infectious Diseases","author":"S Bhangde","year":"2023","unstructured":"Bhangde S, Lodaya RN, Amiji MM. Nanoscale Vaccines for Influenza. In: Patravale VB, Date AA, Jindal AB, editors. Nanomedicines for the Prevention and Treatment of Infectious Diseases. Cham: Springer International Publishing; 2023. pp. 331\u201347. [cited 2024 Oct 6]. https:\/\/doi.org\/10.1007\/978-3-031-39020-3_11."},{"key":"1772_CR5","doi-asserted-by":"publisher","unstructured":"Zwayen S, Zwain T, Singh KK. Targeted drug delivery for antimalarial therapy. In: Drug development for malaria. John Wiley & Sons, Ltd; 2022. pp. 83\u2013104. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1002\/9783527830589.ch4. Accessed 6 Oct 2024.","DOI":"10.1002\/9783527830589.ch4"},{"issue":"2","key":"1772_CR6","doi-asserted-by":"publisher","first-page":"e0247312","DOI":"10.1371\/journal.pone.0247312","volume":"16","author":"A Assefa","year":"2021","unstructured":"Assefa A, Erko B, Gundersen SG, Medhin G, Berhe N. Current status of Schistosoma mansoni infection among previously treated rural communities in the Abbey and Didessa Valleys, Western Ethiopia: Implications for sustainable control. PLoS ONE. 2021;16(2):e0247312.","journal-title":"PLoS ONE"},{"key":"1772_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.1013354\/full","author":"A Qadeer","year":"2022","unstructured":"Qadeer A, Ullah H, Sohail M, Safi SZ, Rahim A, Saleh TA, et al. Potential application of nanotechnology in the treatment, diagnosis, and prevention of schistosomiasis. Front Bioeng Biotechnol. 2022. https:\/\/doi.org\/10.3389\/fbioe.2022.1013354\/full.","journal-title":"Front Bioeng Biotechnol"},{"issue":"5","key":"1772_CR8","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/pharmaceutics14050989","volume":"14","author":"GS Ramos","year":"2022","unstructured":"Ramos GS, Vallejos VMR, Borges GSM, Almeida RM, Alves IM, Aguiar MMG, et al. Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes. Pharmaceutics. 2022;14(5):989.","journal-title":"Pharmaceutics"},{"key":"1772_CR9","doi-asserted-by":"crossref","unstructured":"Bajwa HUR, Khan MK, Abbas Z, Riaz R, Rehman T ur, Abbas RZ et al. Nanoparticles: synthesis and their role as potential drug candidates for the treatment of parasitic diseases. Life. 2022;12(5):750.","DOI":"10.3390\/life12050750"},{"key":"1772_CR10","doi-asserted-by":"publisher","first-page":"108548","DOI":"10.1016\/j.exppara.2023.108548","volume":"250","author":"Q AlGabbani","year":"2023","unstructured":"AlGabbani Q, Nanotechnology. A promising strategy for the control of parasitic infections. Exp Parasitol. 2023;250:108548.","journal-title":"Exp Parasitol"},{"issue":"3","key":"1772_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.14740\/gr1622","volume":"16","author":"M Ahmed","year":"2023","unstructured":"Ahmed M. Intestinal Parasitic Infections in 2023. Gastroenterol Res. 2023;16(3):127\u201340.","journal-title":"Gastroenterol Res"},{"issue":"3","key":"1772_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2217\/nnm.14.116","volume":"10","author":"D Barros","year":"2015","unstructured":"Barros D, Costa Lima SA, Cordeiro-da-Silva A. Surface Functionalization of Polymeric Nanospheres Modulates Macrophage Activation: Relevance in Leishmaniasis Therapy. Nanomed. 2015;10(3):387\u2013403.","journal-title":"Nanomed"},{"key":"1772_CR13","doi-asserted-by":"publisher","unstructured":"Patravale VB, Date AA, Jindal AB, editors. Nanomedicines for the prevention and treatment of infectious diseases. AAPS Advances in the Pharmaceutical Sciences Series; vol. 56. Cham: Springer International Publishing; 2023. https:\/\/doi.org\/10.1007\/978-3-031-39020-3. Accessed 6 Oct 2024.","DOI":"10.1007\/978-3-031-39020-3"},{"key":"1772_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jconrel.2014.11.002","volume":"197","author":"JL Arias","year":"2015","unstructured":"Arias JL, Unciti-Broceta JD, Maceira J, del Castillo T, Hern\u00e1ndez-Quero J, Magez S, et al. Nanobody conjugated PLGA nanoparticles for active targeting of African Trypanosomiasis. J Controlled Release. 2015;197:190\u20138.","journal-title":"J Controlled Release"},{"issue":"9","key":"1772_CR15","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3390\/ijms17091440","volume":"17","author":"PI Siafaka","year":"2016","unstructured":"Siafaka PI, \u00dcst\u00fcnda\u011f Okur N, Karavas E, Bikiaris DN. Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses. Int J Mol Sci. 2016;17(9):1440.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1772_CR16","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1080\/10717544.2019.1692968","volume":"26","author":"Y Sun","year":"2019","unstructured":"Sun Y, Chen D, Pan Y, Qu W, Hao H, Wang X, et al. Nanoparticles for antiparasitic drug delivery. Drug Deliv. 2019;26(1):1206\u201321.","journal-title":"Drug Deliv"},{"issue":"1","key":"1772_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1021\/acsomega.2c05976","volume":"8","author":"S Priya","year":"2023","unstructured":"Priya S, Desai VM, Singhvi G. Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery. ACS Omega. 2023;8(1):74\u201386.","journal-title":"ACS Omega"},{"key":"1772_CR18","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jconrel.2023.08.043","volume":"362","author":"AR Bhide","year":"2023","unstructured":"Bhide AR, Surve DH, Jindal AB. Nanocarrier based active targeting strategies against erythrocytic stage of malaria. J Controlled Release. 2023;362:297\u2013308.","journal-title":"J Controlled Release"},{"issue":"1","key":"1772_CR19","first-page":"374252","volume":"2013","author":"S Salmaso","year":"2013","unstructured":"Salmaso S, Caliceti P. Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers. J Drug Deliv. 2013;2013(1):374252.","journal-title":"J Drug Deliv"},{"key":"1772_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ebiom.2019.06.026","volume":"45","author":"D Kannan","year":"2019","unstructured":"Kannan D, Yadav N, Ahmad S, Namdev P, Bhattacharjee S, Lochab B, et al. Pre-clinical study of iron oxide nanoparticles fortified artesunate for efficient targeting of malarial parasite. EBioMedicine. 2019;45:261\u201377.","journal-title":"EBioMedicine"},{"key":"1772_CR21","doi-asserted-by":"publisher","first-page":"120109","DOI":"10.1016\/j.ijpharm.2020.120109","volume":"593","author":"AS Khan","year":"2021","unstructured":"Khan AS, ud Din F, Ali Z, Bibi M, Zahid F, Zeb A, et al. Development, in vitro and in vivo evaluation of miltefosine loaded nanostructured lipid carriers for the treatment of Cutaneous Leishmaniasis. Int J Pharm. 2021;593:120109.","journal-title":"Int J Pharm"},{"key":"1772_CR22","doi-asserted-by":"crossref","unstructured":"Osman N, Devnarain N, Omolo CA, Fasiku V, Jaglal Y, Govender T. Surface modification of nano\u2010drug delivery systems for enhancing antibiotic delivery and activity. WIREs Nanomedicine Nanobiotechnology. 2022;14(1):e1758.","DOI":"10.1002\/wnan.1758"},{"issue":"3","key":"1772_CR23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/ma12030441","volume":"12","author":"M Mozeti\u010d","year":"2019","unstructured":"Mozeti\u010d M. Surface Modification to Improve Properties of Materials. Materials. 2019;12(3):441.","journal-title":"Materials"},{"issue":"4","key":"1772_CR24","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/acsami.7b16508","volume":"10","author":"A Ivanova","year":"2018","unstructured":"Ivanova A, Ivanova K, Hoyo J, Heinze T, Sanchez-Gomez S, Tzanov T. Layer-By-Layer Decorated Nanoparticles with Tunable Antibacterial and Antibiofilm Properties against Both Gram-Positive and Gram-Negative Bacteria. ACS Appl Mater Interfaces. 2018;10(4):3314\u201323.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"1772_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17425247.2020.1822321","volume":"18","author":"A Ahmed","year":"2021","unstructured":"Ahmed A, Sarwar S, Hu Y, Munir MU, Nisar MF, Ikram F, et al. Surface-modified polymeric nanoparticles for drug delivery to cancer cells. Expert Opin Drug Deliv. 2021;18(1):1\u201324.","journal-title":"Expert Opin Drug Deliv"},{"key":"1772_CR26","doi-asserted-by":"crossref","unstructured":"Sanit\u00e0 G, Carrese B, Lamberti A. Nanoparticle Surface Functionalization: How to Improve Biocompatibility and Cellular Internalization. Front Mol Biosci. 2020;7:587012.","DOI":"10.3389\/fmolb.2020.587012"},{"issue":"44","key":"1772_CR27","doi-asserted-by":"publisher","first-page":"13244","DOI":"10.1021\/acs.langmuir.8b01945","volume":"34","author":"S Oriana","year":"2018","unstructured":"Oriana S, Fracassi A, Archer C, Yamakoshi Y. Covalent Surface Modification of Lipid Nanoparticles by Rapid Potassium Acyltrifluoroborate Amide Ligation. Langmuir. 2018;34(44):13244\u201351.","journal-title":"Langmuir"},{"issue":"35","key":"1772_CR28","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.2174\/0929867325666180601101859","volume":"25","author":"J Schubert","year":"2018","unstructured":"Schubert J, Chanana M. Coating Matters: Review on Colloidal Stability of Nanoparticles with Biocompatible Coatings in Biological Media, Living Cells and Organisms. Curr Med Chem. 2018;25(35):4553\u201386.","journal-title":"Curr Med Chem"},{"issue":"1\u20132","key":"1772_CR29","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijpharm.2016.02.013","volume":"501","author":"A Esmaeili","year":"2016","unstructured":"Esmaeili A, Ghobadianpour S. Vancomycin loaded superparamagnetic MnFe 2 O 4 nanoparticles coated with PEGylated chitosan to enhance antibacterial activity. Int J Pharm. 2016;501(1\u20132):326\u201330.","journal-title":"Int J Pharm"},{"key":"1772_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jconrel.2015.04.028","volume":"209","author":"A Baelo","year":"2015","unstructured":"Baelo A, Levato R, Juli\u00e1n E, Crespo A, Astola J, Gavald\u00e0 J, et al. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections. J Controlled Release. 2015;209:150\u20138.","journal-title":"J Controlled Release"},{"key":"1772_CR31","doi-asserted-by":"crossref","unstructured":"Guyon L, Groo AC, Malzert-Fr\u00e9on ARP. Relevant physicochemical methods to functionalize, purify, and characterize surface-decorated lipid-based nanocarriers. Mol Pharm. 2021;18(1):44\u201364. 10.1021acsmolpharmaceut0c00857.","DOI":"10.1021\/acs.molpharmaceut.0c00857"},{"key":"1772_CR32","doi-asserted-by":"crossref","unstructured":"Jiang S, Wang X, Zhang Z, Sun L, Pu Y, Yao H, Li J, Liu Y, Zhang YZ. W. CD20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of CD20-positive Raji cells. Int J Nanomed. 2016;11:5505\u20135518. 10.2147IJN S115428.","DOI":"10.2147\/IJN.S115428"},{"issue":"6","key":"1772_CR33","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.bbagen.2017.01.035","volume":"1861","author":"S Trabulo","year":"2017","unstructured":"Trabulo S, Aires A, Aicher A, Heeschen C, Cortajarena AL. Multifunctionalized iron oxide nanoparticles for selective targeting of pancreatic cancer cells. Biochim Biophys Acta BBA - Gen Subj. 2017;1861(6):1597\u2013605.","journal-title":"Biochim Biophys Acta BBA - Gen Subj"},{"key":"1772_CR34","first-page":"2","volume":"167","author":"AEA B","year":"2021","unstructured":"B AEA, C AA, A MTFANAA. Ligand decorated biodegradable nanomedicine in the treatment of cancer. Pharm Res. 2021;167:2\u20133.","journal-title":"Pharm Res"},{"issue":"4","key":"1772_CR35","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tcb.2014.12.006","volume":"25","author":"L Seguin","year":"2015","unstructured":"Seguin L, Desgrosellier JS, Weis SM, Cheresh DA. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol. 2015;25(4):234\u201340.","journal-title":"Trends Cell Biol"},{"issue":"30","key":"1772_CR36","doi-asserted-by":"publisher","first-page":"16792","DOI":"10.1021\/acsami.5b04596","volume":"7","author":"Y Liu","year":"2015","unstructured":"Liu Y, Mei L, Yu Q, Xu C, Qiu Y, Yang Y, et al. Multifunctional Tandem Peptide Modified Paclitaxel-Loaded Liposomes for the Treatment of Vasculogenic Mimicry and Cancer Stem Cells in Malignant Glioma. ACS Appl Mater Interfaces. 2015;7(30):16792\u2013801.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1772_CR37","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.colsurfb.2018.12.003","volume":"175","author":"SP Carneiro","year":"2019","unstructured":"Carneiro SP, Carvalho KV, de Oliveira Aguiar Soares RD, Carneiro CM, de Andrade MHG, Duarte RS, et al. Functionalized rifampicin-loaded nanostructured lipid carriers enhance macrophages uptake and antimycobacterial activity. Colloids Surf B Biointerfaces. 2019;175:306\u201313.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"10","key":"1772_CR38","doi-asserted-by":"publisher","first-page":"9693","DOI":"10.1021\/acsnano.8b03800","volume":"12","author":"T Jiang","year":"2018","unstructured":"Jiang T, Wang T, Li T, Ma Y, Shen S, He B, et al. Enhanced Transdermal Drug Delivery by Transfersome-Embedded Oligopeptide Hydrogel for Topical Chemotherapy of Melanoma. ACS Nano. 2018;12(10):9693\u2013701.","journal-title":"ACS Nano"},{"issue":"12","key":"1772_CR39","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00109-013-1085-2","volume":"91","author":"J Banerjee","year":"2013","unstructured":"Banerjee J, Nilsen-Hamilton M. Aptamers: multifunctional molecules for biomedical research. J Mol Med. 2013;91(12):1333\u201342.","journal-title":"J Mol Med"},{"issue":"2","key":"1772_CR40","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3390\/v7020751","volume":"7","author":"T Wandtke","year":"2015","unstructured":"Wandtke T, Wo\u017aniak J, Kopi\u0144ski P. Aptamers in Diagnostics and Treatment of Viral Infections. Viruses. 2015;7(2):751\u201380.","journal-title":"Viruses"},{"key":"1772_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/731516","volume":"2013","author":"FM Zimbres","year":"2013","unstructured":"Zimbres FM, T\u00e1rnok A, Ulrich H, Wrenger C. Aptamers: Novel Molecules as Diagnostic Markers in Bacterial and Viral Infections? BioMed Res Int. 2013;2013:1\u20137.","journal-title":"BioMed Res Int"},{"key":"1772_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.aca.2014.04.055","volume":"837","author":"B Deng","year":"2014","unstructured":"Deng B, Lin Y, Wang C, Li F, Wang Z, Zhang H, et al. Aptamer binding assays for proteins: The thrombin example\u2014A review. Anal Chim Acta. 2014;837:1\u201315.","journal-title":"Anal Chim Acta"},{"issue":"2","key":"1772_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1517\/17460441.2016.1126244","volume":"11","author":"GT Rozenblum","year":"2016","unstructured":"Rozenblum GT, Lopez VG, Vitullo AD, Radrizzani M. Aptamers: current challenges and future prospects. Expert Opin Drug Discov. 2016;11(2):127\u201335.","journal-title":"Expert Opin Drug Discov"},{"issue":"4","key":"1772_CR44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/03639045.2022.2101062","volume":"48","author":"E Sanchez Armengol","year":"2022","unstructured":"Sanchez Armengol E, Unterweger A, Laffleur F. PEGylated drug delivery systems in the pharmaceutical field: past, present and future perspective. Drug Dev Ind Pharm. 2022;48(4):129\u201339.","journal-title":"Drug Dev Ind Pharm"},{"key":"1772_CR45","doi-asserted-by":"publisher","first-page":"104731","DOI":"10.1016\/j.jddst.2023.104731","volume":"86","author":"D Ezhilarasan","year":"2023","unstructured":"Ezhilarasan D, Shree Harini K. Nanodrug delivery: Strategies to circumvent nanoparticle trafficking by Kupffer cells in the liver. J Drug Deliv Sci Technol. 2023;86:104731.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1772_CR46","doi-asserted-by":"crossref","unstructured":"Moku G, Gopalsamuthiram VR, Hoye TR, Panyam J. Surface modification of nanoparticles: Methods and applications. In: Pinson J, Thiry D, editors. Surface modification of polymers: Methods and applications. Wiley-VCH. 2019;317\u201346.","DOI":"10.1002\/9783527819249.ch11"},{"issue":"3","key":"1772_CR47","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.drudis.2019.01.006","volume":"23","author":"A Tomitaka","year":"2019","unstructured":"Tomitaka A, Kaushik A, Kevadiya BD, Mukadam L, Gendelman HE, Khalili K. Surface engineered multimodol magnetic nanoparticles to manage CNS disease. Discov Today. 2019;23(3):873\u201382.","journal-title":"Discov Today"},{"issue":"5","key":"1772_CR48","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s11095-014-1572-3","volume":"32","author":"X Song","year":"2015","unstructured":"Song X, Lin Q, Guo L, Fu Y, Han J, Ke H, et al. Rifampicin Loaded Mannosylated Cationic Nanostructured Lipid Carriers for Alveolar Macrophage-specific Delivery. Pharm Res. 2015;32(5):1741\u201351.","journal-title":"Pharm Res"},{"key":"1772_CR49","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.2147\/DDDT.S104395","volume":"10","author":"M Pinheiro","year":"2016","unstructured":"Pinheiro M, Ribeiro R, Vieira A, Andrade F, Reis S. Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis. Drug Des Devel Ther. 2016;10:2467\u201375.","journal-title":"Drug Des Devel Ther"},{"key":"1772_CR50","doi-asserted-by":"crossref","unstructured":"Lopes JR, Santos G, Barata P, Oliveira R, Lopes CM. Physical and chemical stimuli-responsive drug delivery systems: targeted delivery and main routes of administration. Curr Pharm Des 2013;(Curr Pharm Des 19):7169\u201384.","DOI":"10.2174\/13816128113199990698"},{"key":"1772_CR51","doi-asserted-by":"crossref","unstructured":"Gong C, Wu Q, Wang Y, Zhang D, Luo F, Zhao X, Wei Y, Qian Z. A biodegradable hydrogel system containing curcumin encapsulated in micelles for cutaneous wound healing. Biomaterials. 2013;34(27):6377\u201387.","DOI":"10.1016\/j.biomaterials.2013.05.005"},{"key":"1772_CR52","doi-asserted-by":"crossref","unstructured":"Guragain S, Bastakoti BP, Malgras V, Nakashima K, Yamauchi Y. Multi-Stimuli-Responsive Polymeric Materials. Chemistry. 2015;21(38):13164\u201374.","DOI":"10.1002\/chem.201501101"},{"key":"1772_CR53","doi-asserted-by":"publisher","first-page":"109563","DOI":"10.1155\/2015\/109563","volume":"2015","author":"MT Ansari","year":"2015","unstructured":"Ansari MT, Hussain A, Nadeem S, Majeed H, Saeed-Ul-Hassan S, Tariq I, et al. Preparation and Characterization of Solid Dispersions of Artemether by Freeze-Dried Method. BioMed Res Int. 2015;2015:109563.","journal-title":"BioMed Res Int"},{"key":"1772_CR54","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.biomaterials.2016.01.061","volume":"85","author":"M Kanamala","year":"2016","unstructured":"Kanamala M, Wilson WR, Yang M, Palmer BD. Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a review. Biomaterials. 2016;85:152\u201367.","journal-title":"Biomaterials"},{"key":"1772_CR55","doi-asserted-by":"crossref","unstructured":"Chen X, Liu L, Jiang C. Charge-reversal nanoparticles: novel targeted drug delivery carriers. Acta Pharm Sin B. 2016;6(4):261\u20137.","DOI":"10.1016\/j.apsb.2016.05.011"},{"key":"1772_CR56","doi-asserted-by":"crossref","unstructured":"Rao VR, Upadhyay AK, Kompella UB. pH shift assembly of adenoviral serotype 5 capsid protein nanosystems for enhanced delivery of nanoparticles, proteins and nucleic acids. J Control Release. 2013;172(1):341\u201350.","DOI":"10.1016\/j.jconrel.2013.08.023"},{"issue":"1","key":"1772_CR57","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12936-021-03858-0","volume":"20","author":"PB Memvanga","year":"2021","unstructured":"Memvanga PB, Nkanga CI. Liposomes for malaria management: the evolution from 1980 to 2020. Malar J. 2021;20(1):327.","journal-title":"Malar J"},{"issue":"6","key":"1772_CR58","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.addr.2007.04.009","volume":"59","author":"AA Date","year":"2007","unstructured":"Date AA, Joshi MD, Patravale VB. Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev. 2007;59(6):505\u201321.","journal-title":"Adv Drug Deliv Rev"},{"key":"1772_CR59","doi-asserted-by":"publisher","first-page":"103740","DOI":"10.1016\/j.jddst.2022.103740","volume":"76","author":"H Rashidzadeh","year":"2022","unstructured":"Rashidzadeh H, Tabatabaei Rezaei SJ, Danafar H, Ramazani A. Multifunctional pH-responsive nanogel for malaria and cancer treatment: Hitting two targets with one arrow. J Drug Deliv Sci Technol. 2022;76:103740.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1772_CR60","doi-asserted-by":"crossref","unstructured":"Abera A, Mamecha T, Abose E, Bokicho B, Ashole A, Bishaw T et al. Reemergence of human African trypanosomiasis caused by Trypanosoma brucei rhodesiense, Ethiopia. Emerg Infect Dis J. 2024;30(1). https:\/\/wwwnc.cdc.gov\/eid\/article\/30\/1\/23-1319_article. Accessed 6 Oct 2024.","DOI":"10.3201\/eid3001.231319"},{"key":"1772_CR61","doi-asserted-by":"crossref","unstructured":"Sunita C, Akruti K, Ankit C, Patel JK. Dendrimers in Malaria. In: Shegokar R, Pathak Y, editors. Malarial Drug Delivery Systems. Springer Nature Switzerland; 2023. pp. 139\u201360.","DOI":"10.1007\/978-3-031-15848-3_7"},{"key":"1772_CR62","doi-asserted-by":"publisher","first-page":"123272","DOI":"10.1016\/j.ijbiomac.2023.123272","volume":"230","author":"AC Oliveira","year":"2023","unstructured":"Oliveira AC, de Silva J, Oliveira EB, de Ribeiro TC, de Nadvorny F, de Oliveira D. pH-responsive phthalate cashew gum nanoparticles for improving drugs delivery and anti-Trypanosoma cruzi efficacy. Int J Biol Macromol. 2023;230:123272.","journal-title":"Int J Biol Macromol"},{"key":"1772_CR63","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0022-2836(64)80115-7","volume":"8","author":"AD Movellan","year":"1964","unstructured":"Movellan AD, Horne RW. Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J Mol Biol. 1964;8:660\u2013IN10.","journal-title":"J Mol Biol"},{"key":"1772_CR64","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1096\/fj.10-0503","volume":"24","author":"DW Deamer","year":"2010","unstructured":"Deamer DW. From Banghasomes to liposomes: A memoir of Alec Bangham, 1921\u20132010. FASEB J. 2010;24:1308\u201310.","journal-title":"FASEB J"},{"key":"1772_CR65","doi-asserted-by":"crossref","unstructured":"Luiz H, Oliveira Pinho J, Gaspar MM. Advancing Medicine with Lipid-Based Nanosystems-The Successful Case of Liposomes. Biomedicines. 2023;11(2):435.","DOI":"10.3390\/biomedicines11020435"},{"key":"1772_CR66","doi-asserted-by":"crossref","unstructured":"Tuon FF, Dantas LR, de Souza RM, Ribeiro VST, Amato VS. Liposomal drug delivery systems for the treatment of leishmaniasis. Parasitol Res. 2022;121(11):3073\u201382.","DOI":"10.1007\/s00436-022-07659-5"},{"key":"1772_CR67","doi-asserted-by":"crossref","unstructured":"Ishwarya SP, Anandharamakrishnan C. Liposomal encapsulation of natural color, flavor, and additives for the food industry. Liposomal encapsulation in food science and technology. Volume 1. Elsevier Inc.; 2023. pp. 145\u201367.","DOI":"10.1016\/B978-0-12-823935-3.00001-1"},{"issue":"2","key":"1772_CR68","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00436-013-3685-8","volume":"113","author":"F Ferreira","year":"2014","unstructured":"Ferreira F, et al. Association of water extract of green propolis and liposomal meglumine antimoniate in the treatment of experimental visceral leishmaniasis. Parasitol Res. 2014;113(2):533\u201343.","journal-title":"Parasitol Res"},{"key":"1772_CR69","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","volume":"10","author":"FB Cavassin","year":"2021","unstructured":"Cavassin FB, Ba\u00fa-Carneiro JL, Vilas-Boas RR, Queiroz-Telles F. Sixty years of Amphotericin B: An overview of the main antifungal agent used to treat invasive fungal infections. Infect Ther. 2021;10:115\u201347.","journal-title":"Infect Ther"},{"issue":"8","key":"1772_CR70","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1093\/cid\/ciad313","volume":"77","author":"AC Pasqualotto","year":"2023","unstructured":"Pasqualotto AC, Lana DD, Godoy CSM, Leit\u00e3o T, do MJS, Bay MB, Damasceno LS, et al. Single High Dose of Liposomal Amphotericin B in Human Immunodeficiency Virus\/AIDS-Related Disseminated Histoplasmosis: A Randomized Trial. Clin Infect Dis Off Publ Infect Dis Soc Am. 2023;77(8):1126\u201332.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"1772_CR71","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.nano.2015.06.008","volume":"11","author":"MM Gaspar","year":"2015","unstructured":"Gaspar MM, Calado S, Pereira J, Ferronha H, Correia I, Castro H, et al. Targeted delivery of paromomycin in murine infectious diseases through association to nano lipid systems. Nanomed Nanotechnol Biol Med. 2015;11:1851\u201360.","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"1","key":"1772_CR72","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1080\/10717544.2018.1494222","volume":"25","author":"M Dar","year":"2018","unstructured":"Dar M, Din F, Khan G. Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmania- sis: macrophage as a target cell. Drug Deliv. 2018;25(1):1595\u2013606.","journal-title":"Drug Deliv"},{"key":"1772_CR73","doi-asserted-by":"publisher","first-page":"105256","DOI":"10.1016\/j.ejps.2020.105256","volume":"145","author":"M Dar","year":"2020","unstructured":"Dar M, Khalid S, Varikuti S, Satoskar A, Khan G. Nano-elastic liposomes as multidrug carrier of sodium stibogluconate and ketoconazole: A potential new approach for the topical treatment of cutaneous Leishmaniasis. Eur J Pharm Sci. 2020;145:105256.","journal-title":"Eur J Pharm Sci"},{"key":"1772_CR74","first-page":"1","volume":"13","author":"AV Spirescu","year":"2021","unstructured":"Spirescu AV, Chircov C, Grumezescu AM, Andronescu EA. Polym Nanopart Antimicrob Therapies: Polym. 2021;13:1\u201331.","journal-title":"Polym Nanopart Antimicrob Therapies: Polym"},{"key":"1772_CR75","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jconrel.2016.01.008","volume":"224","author":"H Zazo","year":"2016","unstructured":"Zazo H, Colino CI, Lanao JM. Current applications of nanoparticles in infectious diseases. J Controlled Release. 2016;224:86\u2013102.","journal-title":"J Controlled Release"},{"key":"1772_CR76","doi-asserted-by":"crossref","unstructured":"Saqib M, Ali Bhatti AS, Ahmad NM, Ahmed N, Shahnaz G, Lebaz N, Elaissari A. Amphotericin B Loaded Polymeric Nanoparticles for Treatment of Leishmania Infections. Nanomaterials (Basel). 202;10(6):1152.","DOI":"10.3390\/nano10061152"},{"issue":"800","key":"1772_CR77","first-page":"1","volume":"16","author":"L Resende","year":"2024","unstructured":"Resende L, Sousa D, Helena T, Duarte C, Xavier VF, Coelho A, et al. Benznidazole-Loaded Polymeric Nanoparticles for Oral Chemotherapeutic Treatment of Chagas Disease. Pharmaceutics. 2024;16(800):1\u201321.","journal-title":"Pharmaceutics"},{"key":"1772_CR78","first-page":"e51015","volume":"82","author":"RL McCall","year":"2013","unstructured":"McCall RL, Sirianni RW. PLGA nanoparticles formed by single-or double-emulsion with vitamin E-TPGS. JoVE J Vis Exp. 2013;82:e51015.","journal-title":"JoVE J Vis Exp"},{"key":"1772_CR79","doi-asserted-by":"crossref","unstructured":"Pang J, Wu F, Liao C, Gu Z, Zhang S. Terminal acetylated\/acrylated poly(ethylene glycol) fabricated drug carriers: design, synthesis, and biological evaluation. Biomacromolecules. 2017;18:1956\u20131964.","DOI":"10.1021\/acs.biomac.7b00420"},{"issue":"2","key":"1772_CR80","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/17460441.2020.1681394","volume":"15","author":"AB Vermelho","year":"2020","unstructured":"Vermelho AB, Rodrigues GC, Supuran CT. Why hasn\u2019t there been more progress in new Chagas disease drug discovery? Expert Opin Drug Discov. 2020;15(2):145\u201358.","journal-title":"Expert Opin Drug Discov"},{"key":"1772_CR81","doi-asserted-by":"crossref","unstructured":"Mengarda AC, Iles B, Longo JPF, Moraes J. de. Recent approaches in nanocarrier-based therapies for neglected tropical diseases. WIREs Nanomed Nanobiotechnol. 2023;15:e1852.","DOI":"10.1002\/wnan.1852"},{"key":"1772_CR82","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1128\/AAC.04213-14","volume":"59","author":"K Jain","year":"2015","unstructured":"Jain K, Verma K, Mishra R, Jain K. Targeted Delivery of Amphotericin B: Formulation Development and In vitro and In vivo Evaluation. Antimicrob Agents Chemother. 2015;59:2479\u201387.","journal-title":"Antimicrob Agents Chemother"},{"key":"1772_CR83","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ijpharm.2018.07.030","volume":"548","author":"A Sherje","year":"2018","unstructured":"Sherje A, Jadhav M, Dravyakar B, Kadam D. Dendrimers: a versatile nanocarrier for drug delivery and targeting. Int J Pharm. 2018;548:707\u201320.","journal-title":"Int J Pharm"},{"issue":"4","key":"1772_CR84","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/00914037.2020.1713780","volume":"70","author":"MA Kumar","year":"2021","unstructured":"Kumar MA. Polymeric Materials and Dendrimers in targeted drug delivery applications: a review of diseases and cancer. Int J Polym Mater Polym Biomater. 2021;70(4):287\u201397.","journal-title":"Int J Polym Mater Polym Biomater"},{"key":"1772_CR85","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/joim.12280","volume":"276","author":"RM Kannan","year":"2014","unstructured":"Kannan RM, Nance E, Kannan S, Tomalia DA. Emerging Concepts in Dendrimer-Based Nanomedicine: From Design Principles to Clinical Applications. J Intern Med. 2014;276:579\u2013617.","journal-title":"J Intern Med"},{"key":"1772_CR86","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3390\/ma13030570","volume":"13","author":"C Sandoval-Yanez","year":"2020","unstructured":"Sandoval-Yanez C, Castro R. Dendrimers: amazing platforms for bioactive molecule deliv ery systems. Materials. 2020;13:570.","journal-title":"Materials"},{"issue":"1","key":"1772_CR87","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s11686-021-00459-4","volume":"67","author":"T Elmi","year":"2022","unstructured":"Elmi T, Ardestani MS, Motevalian M, Hesari AK, hamzeh MS, Zamani Z, et al. Antiplasmodial Effect of Nano Dendrimer G2 Loaded with Chloroquine in Mice Infected with Plasmodium berghei. Acta Parasitol. 2022;67(1):298\u2013308.","journal-title":"Acta Parasitol"},{"issue":"8","key":"1772_CR88","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10856-018-6122-9","volume":"29","author":"TZ Mehrizi","year":"2018","unstructured":"Mehrizi TZ, Ardestani MS, Khamesipour A, Hoseini MHM, Mosaffa N, Anissian A, et al. Reduction toxicity of Amphotericin B through loading into a novel nanoformulation of anionic linear globular dendrimer for improve treatment of leishmania major. J Mater Sci Mater Med. 2018;29(8):125.","journal-title":"J Mater Sci Mater Med"},{"key":"1772_CR89","doi-asserted-by":"publisher","first-page":"7940","DOI":"10.1016\/j.biomaterials.2014.05.061","volume":"35","author":"J Movellan","year":"2014","unstructured":"Movellan J, Urb\u00e1n P, Moles E, de la Fuente JM, Sierra T, Serrano JL, et al. Amphiphilic dendritic derivatives as nanocarriers for the targeted delivery of antimalarial drugs. Biomaterials. 2014;35:7940\u201350.","journal-title":"Biomaterials"},{"issue":"2205","key":"1772_CR90","first-page":"2","volume":"23","author":"Z Mhlwatika","year":"2018","unstructured":"Mhlwatika Z, Aderibigbe BA. Application of Dendrimers for the Treatment of Infectious Diseases. Molecules. 2018;23(2205):2\u201332.","journal-title":"Molecules"},{"key":"1772_CR91","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1017\/S0031182020000372","volume":"147","author":"T Elmi","year":"2020","unstructured":"Elmi T, Ardestani MS, Hajialiani F, Motevalian M, Mohamadi M, Sadeghi S, et al. Novel chloroquine loaded curcumin based anionic linear globular dendrimer G2: a metabolomics study on Plasmodium falciparum in vitro using 1 H NMR spectroscopy. Parasitology. 2020;147:747\u201359.","journal-title":"Parasitology"},{"issue":"8","key":"1772_CR92","doi-asserted-by":"publisher","first-page":"7543","DOI":"10.1007\/s11356-015-6007-0","volume":"23","author":"J Subramaniam","year":"2016","unstructured":"Subramaniam J, Murugan K, Panneerselvam C, Kovendan K, Madhiyazhagan P, Dinesh D, et al. Multipurpose effectiveness of Couroupita guianensis-synthesized gold nanoparticles: high antiplasmodial potential, field efficacy against malaria vectors and synergy with Aplocheilus lineatus predators. Environ Sci Pollut Res. 2016;23(8):7543\u201358.","journal-title":"Environ Sci Pollut Res"},{"issue":"39","key":"1772_CR93","doi-asserted-by":"publisher","first-page":"43380","DOI":"10.1021\/acsami.0c09075","volume":"12","author":"S Varela-Aramburu","year":"2020","unstructured":"Varela-Aramburu S, Ghosh C, Goerdeler F, Priegue P, Moscovitz O, Seeberger PH. Targeting and Inhibiting Plasmodium falciparum Using Ultra-small Gold Nanoparticles. ACS Appl Mater Interfaces. 2020;12(39):43380\u20137.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1772_CR94","doi-asserted-by":"publisher","first-page":"106982","DOI":"10.1016\/j.actatropica.2023.106982","volume":"245","author":"D Veeragoni","year":"2023","unstructured":"Veeragoni D, Deshpande SS, Singh V, Misra S, Mutheneni SR. In vitro and in vivo antimalarial activity of green synthesized silver nanoparticles using Sargassum tenerrimum - a marine seaweed. Acta Trop. 2023;245:106982.","journal-title":"Acta Trop"},{"issue":"5","key":"1772_CR95","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/biom12050627","volume":"12","author":"JO Adeyemi","year":"2022","unstructured":"Adeyemi JO, Oriola AO, Onwudiwe DC, Oyedeji AO. Plant Extracts Mediated Metal-Based Nanoparticles: Synthesis and Biological Applications. Biomolecules. 2022;12(5):627.","journal-title":"Biomolecules"},{"issue":"1","key":"1772_CR96","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1080\/21691401.2022.2126979","volume":"50","author":"J Hawadak","year":"2022","unstructured":"Hawadak J, Kojom Foko LP, Pande V, Singh V. In vitro antiplasmodial activity, hemocompatibility and temporal stability of Azadirachta indica silver nanoparticles. Artif Cells Nanomed Biotechnol. 2022;50(1):286\u2013300.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"32","key":"1772_CR97","doi-asserted-by":"publisher","first-page":"40054","DOI":"10.1007\/s11356-020-10027-4","volume":"27","author":"M Murshed","year":"2020","unstructured":"Murshed M, Dkhil MA, Al-Shaebi EM, Qasem MAA, Mares MM, Aljawdah HMA, et al. Biosynthesized silver nanoparticles regulate the iron status in the spleen of Plasmodium chabaudi\u2013infected mice. Environ Sci Pollut Res. 2020;27(32):40054\u201360.","journal-title":"Environ Sci Pollut Res"},{"key":"1772_CR98","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.21931\/RB\/2021.06.03.20","volume":"6","author":"A Al-Abboodi","year":"2021","unstructured":"Al-Abboodi A, Al-Saady H, Banoon S, Al-Saady M. Conjugation strategies on functionalized iron oxide nanoparticles as a malaria vaccine delivery system. Rev Bionatura. 2021;6:2009\u201315.","journal-title":"Rev Bionatura"},{"issue":"39","key":"1772_CR99","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1016\/j.vaccine.2015.08.025","volume":"33","author":"R Kumar","year":"2015","unstructured":"Kumar R, Ray PC, Datta D, Bansal GP, Angov E, Kumar N. Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles. Vaccine. 2015;33(39):5064\u201371.","journal-title":"Vaccine"},{"issue":"3","key":"1772_CR100","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/ced.14919","volume":"47","author":"S Pradhan","year":"2022","unstructured":"Pradhan S, Schwartz RA, Patil A, Grabbe S, Goldust M. Treatment options for leishmaniasis. Clin Exp Dermatol. 2022;47(3):516\u201321.","journal-title":"Clin Exp Dermatol"},{"key":"1772_CR101","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.2147\/IJN.S196421","volume":"14","author":"P Kumar","year":"2019","unstructured":"Kumar P, Shivam P, Mandal S, Prasanna P, Kumar S, Prasad SR, et al. Synthesis, characterization, and mechanistic studies of a gold nanoparticle-amphotericin B covalent conjugate with enhanced antileishmanial efficacy and reduced cytotoxicity. Int J Nanomed. 2019;14:6073\u2013101.","journal-title":"Int J Nanomed"},{"key":"1772_CR102","doi-asserted-by":"publisher","first-page":"102593","DOI":"10.1016\/j.nano.2022.102593","volume":"45","author":"C Castellani","year":"2022","unstructured":"Castellani C, Radu CM, Morillas-Becerril L, Barison I, Menato F, Do Nascimento TM, et al. Poly(lipoic acid)-based nanoparticles as a new therapeutic tool for delivering active molecules. Nanomed Nanotechnol Biol Med. 2022;45:102593.","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"2","key":"1772_CR103","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1021\/acs.biomac.0c01321","volume":"22","author":"JW Trzci\u0144ski","year":"2021","unstructured":"Trzci\u0144ski JW, Morillas-Becerril L, Scarpa S, Tannorella M, Muraca F, Rastrelli F, et al. Poly(lipoic acid)-Based Nanoparticles as Self-Organized, Biocompatible, and Corona-Free Nanovectors. Biomacromolecules. 2021;22(2):467\u201380.","journal-title":"Biomacromolecules"},{"key":"1772_CR104","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.msec.2017.02.145","volume":"75","author":"R Kumar","year":"2017","unstructured":"Kumar R, Pandey K, Sahoo GC, Das S, Das V, Topno RK, et al. Development of high efficacy peptide coated iron oxide nanoparticles encapsulated amphotericin B drug delivery system against visceral leishmaniasis. Mater Sci Eng C Mater Biol Appl. 2017;75:1465\u201371.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"1772_CR105","doi-asserted-by":"publisher","unstructured":"Sidhu AK, Verma N, Kaushal P. Role of biogenic capping agents in the synthesis of metallic nanoparticles and evaluation of their therapeutic potential. Front Nanotechnol. 2022;3. https:\/\/doi.org\/10.3389\/fnano.2021.801620\/full.","DOI":"10.3389\/fnano.2021.801620\/full"},{"key":"1772_CR106","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jphotobiol.2016.05.003","volume":"161","author":"A Ahmad","year":"2016","unstructured":"Ahmad A, Wei Y, Syed F, Khan S, Khan GM, Tahir K, et al. Isatis tinctoria mediated synthesis of amphotericin B-bound silver nanoparticles with enhanced photoinduced antileishmanial activity: A novel green approach. J Photochem Photobiol B. 2016;161:17\u201324.","journal-title":"J Photochem Photobiol B"},{"key":"1772_CR107","doi-asserted-by":"publisher","first-page":"105498","DOI":"10.1016\/j.actatropica.2020.105498","volume":"208","author":"M Bagirova","year":"2020","unstructured":"Bagirova M, Dinparvar S, Allahverdiyev AM, Unal K, Abamor ES, Novruzova M. Investigation of antileshmanial activities of Cuminum cyminum based green silver nanoparticles on L. tropica promastigotes and amastigotes in vitro. Acta Trop. 2020;208:105498.","journal-title":"Acta Trop"},{"key":"1772_CR108","doi-asserted-by":"publisher","first-page":"121698","DOI":"10.1016\/j.ijpharm.2022.121698","volume":"619","author":"T Teixeira Bezerra","year":"2022","unstructured":"Teixeira Bezerra T, Oliveira de Almeida M, Maria de Amorim Lima N, L\u00facia de Castro Rodrigues N, Gomes Pereira Ribeiro V, Jania Teixeira M, et al. In vitro antileishmanial activity of sustainable anacardic acid and cardol based silver nanoparticles on L. braziliensis. Int J Pharm. 2022;619:121698.","journal-title":"Int J Pharm"},{"key":"1772_CR109","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.exppara.2016.09.002","volume":"170","author":"SK Kalangi","year":"2016","unstructured":"Kalangi SK, Dayakar A, Gangappa D, Sathyavathi R, Maurya RS, Narayana Rao D. Biocompatible silver nanoparticles reduced from Anethum graveolens leaf extract augments the antileishmanial efficacy of miltefosine. Exp Parasitol. 2016;170:184\u201392.","journal-title":"Exp Parasitol"},{"key":"1772_CR110","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.ijbiomac.2022.11.326","volume":"227","author":"M Shakeel","year":"2023","unstructured":"Shakeel M, Kiani MH, Sarwar HS, Akhtar S, Rauf A, Ibrahim IM, et al. Emulgel-loaded mannosylated thiolated chitosan-coated silver nanoparticles for the treatment of cutaneous leishmaniasis. Int J Biol Macromol. 2023;227:1293\u2013304.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"1772_CR111","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/pharmaceutics9040053","volume":"9","author":"MA Mohammed","year":"2017","unstructured":"Mohammed MA, Syeda JTM, Wasan KM, Wasan EK. An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery. Pharmaceutics. 2017;9(4):53.","journal-title":"Pharmaceutics"},{"issue":"1","key":"1772_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-72901-y","volume":"10","author":"KEDM Mokbel","year":"2020","unstructured":"Mokbel KEDM, Baiuomy IR, Sabry AEHA, Mohammed MM, El-Dardiry MA. In vivo assessment of the antischistosomal activity of curcumin loaded nanoparticles versus praziquantel in the treatment of Schistosoma mansoni. Sci Rep. 2020;10(1):1\u20139.","journal-title":"Sci Rep"},{"issue":"21","key":"1772_CR113","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2217\/nnm-2021-0161","volume":"16","author":"P Prasanna","year":"2021","unstructured":"Prasanna P, Kumar P, Mandal S, Payal T, Kumar S, Hossain SU, et al. 7,8-Dihydroxyflavone-Functionalized Gold Nanoparticles Target The Arginase Enzyme of Leishmania Donovani. Nanomed. 2021;16(21):1887\u2013903.","journal-title":"Nanomed"},{"issue":"1","key":"1772_CR114","doi-asserted-by":"publisher","first-page":"16209","DOI":"10.1038\/s41598-019-52774-6","volume":"9","author":"S Raj","year":"2019","unstructured":"Raj S, Saha G, Sasidharan S, Dubey VK, Saudagar P. Biochemical characterization and chemical validation of Leishmania MAP Kinase-3 as a potential drug target. Sci Rep. 2019;9(1):16209.","journal-title":"Sci Rep"},{"key":"1772_CR115","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ijbiomac.2022.02.047","volume":"205","author":"S Raj","year":"2022","unstructured":"Raj S, Sasidharan S, Tripathi T, Saudagar P. Biofunctionalized Chrysin-conjugated gold nanoparticles neutralize Leishmania parasites with high efficacy. Int J Biol Macromol. 2022;205:211\u20139.","journal-title":"Int J Biol Macromol"},{"key":"1772_CR116","doi-asserted-by":"publisher","first-page":"106448","DOI":"10.1016\/j.actatropica.2022.106448","volume":"231","author":"S Sasidharan","year":"2022","unstructured":"Sasidharan S, Saudagar P. Gold and silver nanoparticles functionalized with 4\u2019,7-dihydroxyflavone exhibit activity against Leishmania donovani. Acta Trop. 2022;231:106448.","journal-title":"Acta Trop"},{"issue":"14","key":"1772_CR117","doi-asserted-by":"publisher","first-page":"3646","DOI":"10.1111\/febs.16770","volume":"290","author":"S Sasidharan","year":"2023","unstructured":"Sasidharan S, Saudagar P. An anti-leishmanial compound 4\u2032,7-dihydroxyflavone elicits ROS-mediated apoptosis-like death in Leishmania parasite. FEBS J. 2023;290(14):3646\u201363.","journal-title":"FEBS J"},{"issue":"1","key":"1772_CR118","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11686-023-00730-w","volume":"69","author":"SAA Ahmed","year":"2024","unstructured":"Ahmed SAA, Gad SEM, Eida OM, Makhlouf LM. Anti-fibrotic Effect of Oral Versus Intraperitoneal Administration of Gold Nanoparticles in Hepatic Schistosoma mansoni-Infected Mice. Acta Parasitol. 2024;69(1):190\u2013202.","journal-title":"Acta Parasitol"},{"issue":"7","key":"1772_CR119","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.sjbs.2018.02.008","volume":"26","author":"MA Dkhil","year":"2019","unstructured":"Dkhil MA, Khalil MF, Diab MSM, Bauomy AA, Santourlidis S, Al-Shaebi EM, et al. Evaluation of nanoselenium and nanogold activities against murine intestinal schistosomiasis. Saudi J Biol Sci. 2019;26(7):1468\u201372.","journal-title":"Saudi J Biol Sci"},{"key":"1772_CR120","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.2147\/IDR.S216525","volume":"12","author":"AM El-kady","year":"2019","unstructured":"El-kady AM, Ahmed A, Hassan T, El-Deek H, Fouad S, Althagfan SS. Eugenol, a potential schistosomicidal agent with anti-inflammatory and antifibrotic effects against <\u2009em>Schistosoma mansoni, induced liver pathology [Corrigendum]. Infect Drug Resist. 2019;12:2003\u20134.","journal-title":"Infect Drug Resist"},{"key":"1772_CR121","doi-asserted-by":"publisher","first-page":"106952","DOI":"10.1016\/j.actatropica.2023.106952","volume":"244","author":"ZK Hamdan","year":"2023","unstructured":"Hamdan ZK, Soliman MI, Taha HA, Khalil MMH, Nigm AH. Antischistosomal effects of green and chemically synthesized silver nanoparticles: In vitro and in vivo murine model. Acta Trop. 2023;244:106952.","journal-title":"Acta Trop"},{"issue":"3","key":"1772_CR122","doi-asserted-by":"publisher","first-page":"e202301929","DOI":"10.1002\/cbdv.202301929","volume":"21","author":"LVF Oliveira","year":"2024","unstructured":"Oliveira LVF, Camilo FF, Soares MG, Cajas RA, Cirino ME, de Moraes J, et al. In Situ Preparation of Dehydrodieugenol-Loaded Silver Nanoparticles and their Antischistosomal Activity. Chem Biodivers. 2024;21(3):e202301929.","journal-title":"Chem Biodivers"},{"key":"1772_CR123","doi-asserted-by":"crossref","unstructured":"Kumar P, Shivam P, Mandal S, Prasanna P, Kumar S, Prasad SR, et al. Synthesis, characterization, and mechanistic studies of a gold nanoparticle\u2013amphotericin B covalent conjugate with enhanced antileishmanial efficacy and reduced cytotoxicity.Int J Nanomed. 2019;14:6073\u2013101.","DOI":"10.2147\/IJN.S196421"},{"key":"1772_CR124","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.msec.2017.02.145","volume":"75","author":"R Kumar","year":"2017","unstructured":"Kumar R, Pandey K, Sahoo GC, Das S, Das V, Topno R, et al. Development of high efficacy peptide coated iron oxide nanoparticles encapsulated amphotericin B drug delivery system against visceral leishmaniasis. Mater Sci Eng C. 2017;75:1465\u201371.","journal-title":"Mater Sci Eng C"},{"issue":"3","key":"1772_CR125","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/13543776.2020.1720649","volume":"30","author":"R Paliwal","year":"2020","unstructured":"Paliwal R, Paliwal SR, Kenwat R, Kurmi BD, Sahu MK. Solid lipid nanoparticles: a review on recent perspectives and patents. Expert Opin Ther Pat. 2020;30(3):179\u201394.","journal-title":"Expert Opin Ther Pat"},{"issue":"3","key":"1772_CR126","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1515\/ejnm-2016-0009","volume":"8","author":"AA Attama","year":"2016","unstructured":"Attama AA, Kenechukwu FC, Onuigbo EB, Nnamani PO, Obitte N, Finke JH, et al. Solid lipid nanoparticles encapsulating a fluorescent marker (coumarin 6) and antimalarials \u2013 artemether and lumefantrine: evaluation of cellular uptake and antimalarial activity. Eur J Nanomed. 2016;8(3):129\u201338.","journal-title":"Eur J Nanomed"},{"issue":"3","key":"1772_CR127","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1039\/D3MA00817G","volume":"5","author":"SC Emencheta","year":"2024","unstructured":"Emencheta SC, Onugwu AL, Kalu CF, Ezinkwo PN, Eze OC, Vila MMDC, et al. Bacteriophages as nanocarriers for targeted drug delivery and enhanced therapeutic effects. Mater Adv. 2024;5(3):986\u20131016.","journal-title":"Mater Adv"},{"issue":"1","key":"1772_CR128","first-page":"3865","volume":"9","author":"WN Omwoyo","year":"2014","unstructured":"Omwoyo WN, Ogutu B, Oloo F, Swai H, Kalombo L, Melariri P, et al. Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles. Int J Nanomed. 2014;9(1):3865\u201374.","journal-title":"Int J Nanomed"},{"issue":"1","key":"1772_CR129","first-page":"9780489","volume":"2018","author":"M Rodriguez-Torres","year":"2018","unstructured":"Rodriguez-Torres M, del P, Acosta-Torres LS, Diaz-Torres LA. Heparin-Based Nanoparticles: An Overview of Their Applications. J Nanomater. 2018;2018(1):9780489.","journal-title":"J Nanomater"},{"issue":"8","key":"1772_CR130","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.nano.2014.06.002","volume":"10","author":"J Marques","year":"2014","unstructured":"Marques J, Moles E, Urb\u00e1n P, Prohens R, Busquets MA, Sevrin C, et al. Application of heparin as a dual agent with antimalarial and liposome targeting activities toward Plasmodium-infected red blood cells. Nanomed Nanotechnol Biol Med. 2014;10(8):1719\u201328.","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"1","key":"1772_CR131","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12936-018-2302-9","volume":"17","author":"JO Muga","year":"2018","unstructured":"Muga JO, Gathirwa JW, Tukulula M, Jura WGZO. In vitro evaluation of chloroquine-loaded and heparin surface-functionalized solid lipid nanoparticles. Malar J. 2018;17(1):133.","journal-title":"Malar J"},{"issue":"1","key":"1772_CR132","doi-asserted-by":"publisher","first-page":"12243","DOI":"10.1038\/s41598-020-69276-5","volume":"10","author":"S Parvez","year":"2020","unstructured":"Parvez S, Yadagiri G, Gedda MR, Singh A, Singh OP, Verma A, et al. Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis. Sci Rep. 2020;10(1):12243.","journal-title":"Sci Rep"},{"key":"1772_CR133","doi-asserted-by":"publisher","first-page":"111279","DOI":"10.1016\/j.msec.2020.111279","volume":"117","author":"A Singh","year":"2020","unstructured":"Singh A, Yadagiri G, Parvez S, Singh OP, Verma A, Sundar S, et al. Formulation, characterization and in vitro anti-leishmanial evaluation of amphotericin B loaded solid lipid nanoparticles coated with vitamin B12-stearic acid conjugate. Mater Sci Eng C. 2020;117:111279.","journal-title":"Mater Sci Eng C"},{"key":"1772_CR134","doi-asserted-by":"publisher","first-page":"106342","DOI":"10.1016\/j.actatropica.2022.106342","volume":"229","author":"EI Ibrahim","year":"2022","unstructured":"Ibrahim EI, Abou-El-Naga IF, El-Temsahy MM, Elsawy ESA, Makled S, Mogahed NMFH. A single oral dose of celecoxib-loaded solid lipid nanoparticles for treatment of different developmental stages of experimental schistosomiasis mansoni. Acta Trop. 2022;229:106342.","journal-title":"Acta Trop"},{"key":"1772_CR135","doi-asserted-by":"publisher","first-page":"108552","DOI":"10.1016\/j.exppara.2023.108552","volume":"251","author":"NMFH Mogahed","year":"2023","unstructured":"Mogahed NMFH, El-Temsahy MM, Abou-El-Naga IF, Makled S, Sheta E, Ibrahim EI. Loading praziquantel within solid lipid nanoparticles improved its schistosomicidal efficacy against the juvenile stage. Exp Parasitol. 2023;251:108552.","journal-title":"Exp Parasitol"},{"key":"1772_CR136","doi-asserted-by":"crossref","unstructured":"Souza ALR de, Andreani T, de Oliveira RN, K CP, Santos FK dos, Allegretti SM, et al. In vitro evaluation of permeation, toxicity and effect of praziquantel-loaded solid lipid nanoparticles against Schistosoma mansoni as a strategy to improve efficacy of the schistosomiasis treatment. Int J Pharm. 2014;463(1):31\u20137.","DOI":"10.1016\/j.ijpharm.2013.12.022"},{"issue":"6","key":"1772_CR137","doi-asserted-by":"publisher","first-page":"e26868","DOI":"10.1016\/j.heliyon.2024.e26868","volume":"10","author":"PA Odera","year":"2024","unstructured":"Odera PA, Otieno G, Onyango JO, Owuor JJ, Oloo FA, Ongas M, et al. NANOPARTICLE-BASED formulation of dihydroartemisinin-lumefantrine duo-drugs: Preclinical Evaluation and enhanced antimalarial efficacy in a mouse model. Heliyon. 2024;10(6):e26868.","journal-title":"Heliyon"},{"issue":"3","key":"1772_CR138","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3390\/ijms22031141","volume":"22","author":"Y Boateng-Marfo","year":"2021","unstructured":"Boateng-Marfo Y, Dong Y, Ng WK, Lin HS. Artemether-Loaded Zein Nanoparticles: An Innovative Intravenous Dosage Form for the Management of Severe Malaria. Int J Mol Sci. 2021;22(3):1141.","journal-title":"Int J Mol Sci"},{"issue":"August 2023","key":"1772_CR139","doi-asserted-by":"publisher","first-page":"114210","DOI":"10.1016\/j.ejpb.2024.114210","volume":"197","author":"M Raza","year":"2024","unstructured":"Raza M, Bharti H, Chauhan C, Singal A, Jha D, Ghosh P, et al. Enhanced anti-malarial efficacy of mefloquine delivered via cationic liposome in a murine model of experimental cerebral malaria. Eur J Pharm Biopharm. 2024;197(August 2023):114210.","journal-title":"Eur J Pharm Biopharm"},{"key":"1772_CR140","doi-asserted-by":"crossref","unstructured":"Goli VVN, Tatineni S, Hani U, Ghazwani M, Talath S, Sridhar SB et al. Pharmacokinetics and pharmacodynamics of a nanostructured lipid carrier co-encapsulating artemether and mirna for mitigating cerebral malaria. Pharmaceuticals. 2024;17(4).","DOI":"10.3390\/ph17040466"},{"key":"1772_CR141","doi-asserted-by":"publisher","first-page":"102125","DOI":"10.1016\/j.jddst.2020.102125","volume":"61","author":"CE Umeyor","year":"2021","unstructured":"Umeyor CE, Okoye I, Uronnachi E, Okeke T, Kenechukwu F, Attama A. Repositioning miconazole nitrate for malaria: Formulation of sustained release nanostructured lipid carriers, structure characterization and in vivo antimalarial evaluation. J Drug Deliv Sci Technol. 2021;61:102125.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"MAY","key":"1772_CR142","first-page":"1","volume":"9","author":"O Oyeyemi","year":"2018","unstructured":"Oyeyemi O, Morenkeji O, Afolayan F, Dauda K, Busari Z, Meena J, et al. Curcumin-artesunate based polymeric nanoparticle; Antiplasmodial and toxicological evaluation in murine model. Front Pharmacol. 2018;9(MAY):1\u20138.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1772_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-10672-9","volume":"7","author":"C Dende","year":"2017","unstructured":"Dende C, Meena J, Nagarajan P, Nagaraj VA, Panda AK, Padmanaban G. Nanocurcumin is superior to native curcumin in preventing degenerative changes in Experimental Cerebral Malaria. Sci Rep. 2017;7(1):1\u201312.","journal-title":"Sci Rep"},{"issue":"P2","key":"1772_CR144","doi-asserted-by":"publisher","first-page":"133220","DOI":"10.1016\/j.ijbiomac.2024.133220","volume":"273","author":"D Pradhan","year":"2024","unstructured":"Pradhan D, Biswasroy P, Ramchandani M, Pradhan DK, Bhola RK, Goyal A, et al. Development, characterization, and evaluation of withaferin-A and artesunate-loaded pH-responsive acetal-dextran polymeric nanoparticles for the management of malaria. Int J Biol Macromol. 2024;273(P2):133220.","journal-title":"Int J Biol Macromol"},{"issue":"MAR","key":"1772_CR145","first-page":"1","volume":"10","author":"KL Wilson","year":"2019","unstructured":"Wilson KL, Pouniotis D, Hanley J, Xiang SD, Ma C, Coppel RL, et al. A synthetic nanoparticle based vaccine approach targeting MSP4\/5 is immunogenic and induces moderate protection against murine blood-stage malaria. Front Immunol. 2019;10(MAR):1\u201312.","journal-title":"Front Immunol"},{"issue":"January","key":"1772_CR146","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jconrel.2021.01.028","volume":"331","author":"A Biosca","year":"2021","unstructured":"Biosca A, Cabanach P, Abdulkarim M, Gumbleton M, G\u00f3mez-Canela C, Ram\u00edrez M, et al. Zwitterionic self-assembled nanoparticles as carriers for Plasmodium targeting in malaria oral treatment. J Controlled Release. 2021;331(January):364\u201375.","journal-title":"J Controlled Release"},{"key":"1772_CR147","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jgar.2020.02.018","volume":"22","author":"H Kathpalia","year":"2020","unstructured":"Kathpalia H, Juvekar S, Mohanraj K, Apsingekar M, Shidhaye S. H-based precipitation method and its pharmacodynamic properties in a novel artemisinin combination. J Glob Antimicrob Resist. 2020;22:248\u201356.","journal-title":"J Glob Antimicrob Resist"},{"issue":"February","key":"1772_CR148","doi-asserted-by":"publisher","first-page":"105382","DOI":"10.1016\/j.ejps.2020.105382","volume":"151","author":"MG Silva","year":"2020","unstructured":"Silva MG, Da, Cardoso JF, Perasoli FB, Branquinho RT, Mour\u00e3o RS, Tavares HDS, et al. Nanoemulsion composed of 10-(4,5-dihydrothiazol-2-yl)thio)decan-1-ol), a synthetic analog of 3-alkylpiridine marine alkaloid: development, characterization, and antimalarial activity. Eur J Pharm Sci. 2020;151(February):105382.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"1772_CR149","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1080\/07391102.2023.2201855","volume":"42","author":"D Pradhan","year":"2024","unstructured":"Pradhan D, Biswasroy P, Kulkarni S, Taliyan R, Pradhan DK, Bhola RK, et al. Identification of starvation-mimetic bioactive phytocomponent from Withania somnifera using in-silico molecular modelling and flow cytometry-based analysis for the management of malaria. J Biomol Struct Dyn. 2024;42(1):528\u201349.","journal-title":"J Biomol Struct Dyn"},{"key":"1772_CR150","doi-asserted-by":"publisher","first-page":"117999","DOI":"10.1016\/j.carbpol.2021.117999","volume":"264","author":"Q Hu","year":"2021","unstructured":"Hu Q, Lu Y, Luo Y. Recent advances in dextran-based drug delivery systems: From fabrication strategies to applications. Carbohydr Polym. 2021;264:117999.","journal-title":"Carbohydr Polym"},{"issue":"3","key":"1772_CR151","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3390\/molecules28031086","volume":"28","author":"AR Petrovici","year":"2023","unstructured":"Petrovici AR, Pinteala M, Simionescu N. Dextran Formulations as Effective Delivery Systems of Therapeutic Agents. Molecules. 2023;28(3):1086.","journal-title":"Molecules"},{"key":"1772_CR152","doi-asserted-by":"crossref","unstructured":"Kashyap A, Kaur R, Baldi A, Jain UK, Chandra R, Madan J. Chloroquine diphosphate bearing dextran nanoparticles augmented drug delivery and overwhelmed drug resistance in Plasmodium falciparum parasites. Int J Biol Macromol. 2018;114:161\u20138.","DOI":"10.1016\/j.ijbiomac.2018.03.102"},{"key":"1772_CR153","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ijbiomac.2022.02.006","volume":"204","author":"A Singh","year":"2022","unstructured":"Singh A, Yadagiri G, Negi M, Kushwaha AK, Singh OP, Sundar S, et al. Carboxymethyl chitosan modified lipid nanoformulations as a highly efficacious and biocompatible oral anti-leishmanial drug carrier system. Int J Biol Macromol. 2022;204:373\u201385.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"1772_CR154","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1021\/acsinfecdis.3c00564","volume":"10","author":"A Najer","year":"2024","unstructured":"Najer A, Kim J, Saunders C, Che J, Baum J, Stevens MM. Enhanced Antimalarial and Antisequestration Activity of Methoxybenzenesulfonate-Modified Biopolymers and Nanoparticles for Tackling Severe Malaria. ACS Infect Dis. 2024;10(2):732\u201345.","journal-title":"ACS Infect Dis"},{"key":"1772_CR155","doi-asserted-by":"publisher","first-page":"8659","DOI":"10.2147\/IJN.S262642","volume":"15","author":"J Rebou\u00e7as-Silva","year":"2020","unstructured":"Rebou\u00e7as-Silva J, Tadini MC, Devequi-Nunes D, Mansur AL, Silveira-Mattos PS, de Oliveira CI, et al. Evaluation of in vitro and in vivo efficacy of a novel amphotericin B-loaded nanostructured lipid carrier in the treatment of Leishmania braziliensis infection. Int J Nanomed. 2020;15:8659\u201372.","journal-title":"Int J Nanomed"},{"key":"1772_CR156","doi-asserted-by":"crossref","unstructured":"de Souza ML, Sales V de AW, Sales SG dos S, Sales J\u00fanior PA, Pereira VRA, de Fran\u00e7a EJ, et al. Nanostructured Lipid Carriers for oral treatment of leishmaniasis: Design and preclinical evaluation. Colloids Surf Physicochem Eng Asp. 2024;694:134140.","DOI":"10.1016\/j.colsurfa.2024.134140"},{"key":"1772_CR157","doi-asserted-by":"publisher","first-page":"105335","DOI":"10.1016\/j.ejps.2020.105335","volume":"150","author":"JG Galv\u00e3o","year":"2020","unstructured":"Galv\u00e3o JG, Santos RL, Silva ARST, Santos JS, Costa AMB, Chandasana H, et al. Carvacrol loaded nanostructured lipid carriers as a promising parenteral formulation for leishmaniasis treatment. Eur J Pharm Sci. 2020;150:105335.","journal-title":"Eur J Pharm Sci"},{"key":"1772_CR158","doi-asserted-by":"crossref","unstructured":"Monteiro LM, L\u00f6benberg R, Barbosa EJ, de Araujo GLB, Sato PK, Kanashiro E, de Araujo Eliodoro RH, Rocha M, de Freitas VLT, Fotaki N, Bou-Chacra NA. Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum. Eur J Pharm Sci. 2022;169:106097.","DOI":"10.1016\/j.ejps.2021.106097"},{"key":"1772_CR159","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ejpb.2020.05.029","volume":"152","author":"H Shoaib Sarwar","year":"2020","unstructured":"Shoaib Sarwar H, Varikuti S, Farhan Sohail M, Sarwar M, Akhtar S, Satoskar AR, et al. Oral delivery and enhanced efficacy of antimonal drug through macrophage-guided multifunctional nanocargoes against visceral Leishmaniasis. Eur J Pharm Biopharm. 2020;152:307\u201317.","journal-title":"Eur J Pharm Biopharm"},{"key":"1772_CR160","doi-asserted-by":"publisher","first-page":"105295","DOI":"10.1016\/j.ejps.2020.105295","volume":"147","author":"AT Horoiwa","year":"2020","unstructured":"Horoiwa AT, Cortez M, Sauter IP, Migotto A, Bandeira CL, Cerize NNP, et al. Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation. Eur J Pharm Sci. 2020;147:105295.","journal-title":"Eur J Pharm Sci"},{"key":"1772_CR161","first-page":"16","volume":"8","author":"SJ Chowdhary","year":"2016","unstructured":"Chowdhary SJ, Chowdhary A. Kashaw. Macrophage targeting: a strategy for leishmaniasis specific delivery. Int J Pharm Pharm. 2016;8:16\u201326.","journal-title":"Int J Pharm Pharm"},{"key":"1772_CR162","doi-asserted-by":"crossref","unstructured":"Abdel-Wahab AA, Shafey DA, Selim SM, Sharaf SA, Mohsen KK, Allam DM, et al. Spiramycin-loaded maltodextrin nanoparticles as a promising treatment of toxoplasmosis on murine model. Parasitol Res. 2024;123(7):286.","DOI":"10.1007\/s00436-024-08280-4"},{"issue":"3","key":"1772_CR163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0010268","volume":"16","author":"NAE Hagras","year":"2022","unstructured":"Hagras NAE, Mogahed NMFH, Sheta E, Darwish AAE, El-Hawary MA, Hamed MT, et al. The powerful synergistic effect of spiramycin\/ propolis loaded chitosan\/alginate nanoparticles on acute murine toxoplasmosis. PLoS Negl Trop Dis. 2022;16(3):1\u201322.","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"1772_CR164","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/03639045.2021.1908339","volume":"47","author":"AR Said","year":"2021","unstructured":"Said AR, Zoghroban HS, Arafa MF, Mahmoud SS, El Maghraby GM. Nanostructured lipid carriers for enhanced in vitro and in vivo schistosomicidal activity of praziquantel: effect of charge. Drug Dev Ind Pharm. 2021;47(4):663\u201372.","journal-title":"Drug Dev Ind Pharm"},{"issue":"1","key":"1772_CR165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-020-04346-1","volume":"13","author":"MM Eissa","year":"2020","unstructured":"Eissa MM, El-Azzouni MZ, El-Khordagui LK, Abdel Bary A, El-Moslemany RM, Abdel Salam SA. Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni. Parasit Vectors. 2020;13(1):1\u201312.","journal-title":"Parasit Vectors"},{"key":"1772_CR166","doi-asserted-by":"crossref","unstructured":"Adekiya TA, Kumar P, Kondiah PPD, Choonara YE. In vivo Evaluation of an Antibody-Functionalized Lipoidal Nanosystem for Schistosomiasis Intervention. Pharmaceutics. 2022;14(8):1531.","DOI":"10.3390\/pharmaceutics14081531"},{"issue":"11","key":"1772_CR167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/life12111834","volume":"12","author":"MM El-Derbawy","year":"2022","unstructured":"El-Derbawy MM, Salem HS, Raboo M, Baiuomy IR, Fadil SA, Fadil HA, et al. In Vivo Evaluation of the Anti-Schistosomal Potential of Ginger-Loaded Chitosan Nanoparticles on Schistosoma mansoni: Histopathological, Ultrastructural, and Immunological Changes. Life. 2022;12(11):1\u201314.","journal-title":"Life"},{"key":"1772_CR168","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.2147\/IJN.S254808","volume":"15","author":"SJ Park","year":"2020","unstructured":"Park SJ. Protein\u2013Nanoparticle Interaction: Corona Formation and Conformational Changes in Proteins on Nanoparticles. Int J Nanomed. 2020;15:5783\u2013802.","journal-title":"Int J Nanomed"},{"issue":"11","key":"1772_CR169","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1021\/acsmacrolett.5b00627","volume":"4","author":"Q Dai","year":"2015","unstructured":"Dai Q, Yan Y, Guo J, Bj\u00f6rnmalm M, Cui J, Sun H, et al. Targeting Ability of Affibody-Functionalized Particles Is Enhanced by Albumin but Inhibited by Serum Coronas. ACS Macro Lett. 2015;4(11):1259\u201363.","journal-title":"ACS Macro Lett"},{"key":"1772_CR170","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.biomaterials.2015.10.019","volume":"75","author":"V Mirshafiee","year":"2016","unstructured":"Mirshafiee V, Kim R, Park S, Mahmoudi M, Kraft ML. Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake. Biomaterials. 2016;75:295\u2013304.","journal-title":"Biomaterials"},{"issue":"15","key":"1772_CR171","doi-asserted-by":"publisher","first-page":"2006298","DOI":"10.1002\/smll.202006298","volume":"17","author":"N Burden","year":"2021","unstructured":"Burden N, Clift MJD, Jenkins GJS, Labram B, Sewell F. Opportunities and Challenges for Integrating New In Vitro Methodologies in Hazard Testing and Risk Assessment. Small. 2021;17(15):2006298.","journal-title":"Small"},{"key":"1772_CR172","doi-asserted-by":"publisher","unstructured":"Jindal AB. Size reduction. In: Jindal AB, editor. Pharmaceutical process engineering and scale-up principles. Cham: Springer Nature Switzerland; 2023. pp. 99\u2013110.https:\/\/doi.org\/10.1007\/978-3-031-31380-6_8.","DOI":"10.1007\/978-3-031-31380-6_8"},{"key":"1772_CR173","doi-asserted-by":"crossref","unstructured":"Shegokar R, Nakach M. Chapter 4\u2014Large-scale manufacturing of nanoparticles\u2014an industrial outlook. In: Shegokar R, editor. Drug delivery aspects. Elsevier; 2020. pp. 57\u201377. https:\/\/www.sciencedirect.com\/science\/article\/pii\/B978012821222600004X.","DOI":"10.1016\/B978-0-12-821222-6.00004-X"},{"key":"1772_CR174","doi-asserted-by":"publisher","unstructured":"Patel JK, Pathak YV, editors. Emerging technologies for nanoparticle manufacturing. Cham: Springer International Publishing; 2021. https:\/\/doi.org\/10.1007\/978-3-030-50703-9.","DOI":"10.1007\/978-3-030-50703-9"},{"key":"1772_CR175","doi-asserted-by":"publisher","first-page":"102331","DOI":"10.1016\/j.jddst.2021.102331","volume":"61","author":"MS Mirtaleb","year":"2021","unstructured":"Mirtaleb MS, Shahraky MK, Ekrami E, Mirtaleb A. Advances in biological nano-phospholipid vesicles for transdermal delivery: A review on applications. J Drug Deliv Sci Technol. 2021;61:102331.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"30","key":"1772_CR176","doi-asserted-by":"publisher","first-page":"20495","DOI":"10.1039\/D3RA02248J","volume":"13","author":"X Hu","year":"2023","unstructured":"Hu X, Wang T, Li F, Mao X. Surface modifications of biomaterials in different applied fields. RSC Adv. 2023;13(30):20495\u2013511.","journal-title":"RSC Adv"},{"issue":"6","key":"1772_CR177","doi-asserted-by":"publisher","first-page":"e1809","DOI":"10.1002\/wnan.1809","volume":"14","author":"LM Moll\u00e9","year":"2022","unstructured":"Moll\u00e9 LM, Smyth CH, Yuen D, Johnston APR. Nanoparticles for vaccine and gene therapy: Overcoming the barriers to nucleic acid delivery. WIREs Nanomed Nanobiotechnol. 2022;14(6):e1809.","journal-title":"WIREs Nanomed Nanobiotechnol"},{"issue":"9","key":"1772_CR178","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3390\/coatings13091660","volume":"13","author":"A Abdelkawi","year":"2023","unstructured":"Abdelkawi A, Slim A, Zinoune Z, Pathak Y. Surface Modification of Metallic Nanoparticles for Targeting Drugs. Coatings. 2023;13(9):1660.","journal-title":"Coatings"},{"issue":"45","key":"1772_CR179","doi-asserted-by":"publisher","first-page":"42014","DOI":"10.1021\/acsomega.3c04587","volume":"8","author":"R Tiwari","year":"2023","unstructured":"Tiwari R, Gupta RP, Singh VK, Kumar A, Rajneesh, Madhukar P, et al. Nanotechnology-Based Strategies in Parasitic Disease Management: From Prevention to Diagnosis and Treatment. ACS Omega. 2023;8(45):42014\u201327.","journal-title":"ACS Omega"},{"issue":"8","key":"1772_CR180","doi-asserted-by":"publisher","first-page":"471","DOI":"10.26538\/tjnpr\/v4i8.24","volume":"4","author":"CS Nwagwu","year":"2020","unstructured":"Nwagwu CS, Ogbonna JDN, Nwobi LG, Echezona AC, Ugwu CN, Ezeibe EN, Ozioko AC, Nnamani PO, Attama AA. Development, and Evaluation of the Repellent Activity of Azadirachta indica Oil-Based Solid Lipid Microparticles against Aedes aegypti (Linn). Trop J Nat Prod Res. 2020;4(8):471\u20138. https:\/\/doi.org\/10.26538\/tjnpr\/v4i8.24.","journal-title":"Trop J Nat Prod Res"},{"key":"1772_CR181","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1039\/D4NA00474D","volume":"6","author":"CS Nwagwu","year":"2024","unstructured":"Nwagwu CS, Onugwu A, Echezona A, Uzondu S, Agbo C, Kenechukwu F, Ogbonna J, Ugorji L, Nwobi L, Nwobi O, Mmuotoo O, Ezeibe E, Loretz B, Tarirai C, Mbara KC, Agumah N, Nnamani P, Ofokansi K, Lehr C-M, Attama A. Biopolymeric and lipid-based nanotechnological strategies for the design and development of novel mosquito repellent systems: Recent advances. Nanoscale Adv. 2024;6:4751\u201380. https:\/\/doi.org\/10.1039\/D4NA00474D.","journal-title":"Nanoscale Adv"},{"issue":"26","key":"1772_CR182","doi-asserted-by":"publisher","first-page":"16238","DOI":"10.1021\/acsomega.0c02032","volume":"5","author":"D Alti","year":"2020","unstructured":"Alti D, Veeramohan Rao M, Rao DN, Maurya R, Kalangi SK. Gold\u2013Silver Bimetallic Nanoparticles Reduced with Herbal Leaf Extracts Induce ROS-Mediated Death in Both Promastigote and Amastigote Stages of Leishmania donovani. ACS Omega. 2020;5(26):16238\u201345.","journal-title":"ACS Omega"},{"key":"1772_CR183","doi-asserted-by":"publisher","first-page":"111294","DOI":"10.1016\/j.biopha.2021.111294","volume":"137","author":"MA Awad","year":"2021","unstructured":"Awad MA, Al Olayan EM, Siddiqui MI, Merghani NM, Alsaif SSA, llah, Aloufi AS. Antileishmanial effect of silver nanoparticles: Green synthesis, characterization, in vivo and in vitro assessment. Biomed Pharmacother. 2021;137:111294.","journal-title":"Biomed Pharmacother"},{"key":"1772_CR184","doi-asserted-by":"publisher","unstructured":"Gedda MR, Madhukar P, Vishwakarma AK, Verma V, Kushwaha AK, Yadagiri G et al. Evaluation of safety and antileishmanial efficacy of amine functionalized carbon-based composite nanoparticle appended with amphotericin B: an in vitro and preclinical study. Front Chem. 2020;8. https:\/\/doi.org\/10.3389\/fchem.2020.00510\/full.","DOI":"10.3389\/fchem.2020.00510\/full"},{"issue":"1","key":"1772_CR185","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1080\/21691401.2019.1596923","volume":"47","author":"G Omarch","year":"2019","unstructured":"Omarch G, Kippie Y, Mentor S, Ebrahim N, Fisher D, Murilla G, et al. Comparative in vitro transportation of pentamidine across the blood-brain barrier using polycaprolactone nanoparticles and phosphatidylcholine liposomes. Artif Cells Nanomed Biotechnol. 2019;47(1):1428\u201336.","journal-title":"Artif Cells Nanomed Biotechnol"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-026-01772-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-026-01772-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-026-01772-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T09:01:56Z","timestamp":1777626116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13065-026-01772-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":185,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1772"],"URL":"https:\/\/doi.org\/10.1186\/s13065-026-01772-7","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"10 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}